Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors

Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors

US Patent 10766873 · Granted Sep 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endoth2018
Polypeptides and nucleic acids for treating ErbB2-dependent cancers2015